SCHEMBL147359

SCHEMBL147359

[CH]=CCCC/C=C/CCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.38
FAAH O00519 3/20 0.37
TERT O14746 3/20 0.32
MAPT P10636 2/20 0.32
BLM P54132 2/20 0.32
HSD17B10 Q99714 2/20 0.32
FABP4 P15090 2/20 0.32
F7 P08709 2/20 0.32
F3 P13726 2/20 0.32
PTPN1 P18031 2/20 0.32
PPARG P37231 2/20 0.32
PPARD Q03181 2/20 0.32
PPARA Q07869 2/20 0.32
GMNN O75496 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29284320 1.00 TRPV1 (0.38) TRPV1FAAHTERTMAPTBLM
SCHEMBL147360 1.00 TRPV1 (0.38) TRPV1FAAHTERTMAPTBLM
SCHEMBL7289255 0.94 FAAH (0.42) TRPV1FAAHTERTMAPTBLM
SCHEMBL7289260 0.94 FAAH (0.42) TRPV1FAAHTERTMAPTBLM
SCHEMBL29284290 0.93 TRPV1 (0.48) TRPV1FAAHMAPTBLMHSD17B10
SCHEMBL25185950 0.92 FAAH (0.46) TRPV1FAAHTERTMAPTBLM
SCHEMBL25181812 0.92 FAAH (0.46) TRPV1FAAHTERTMAPTBLM
SCHEMBL21694548 0.92 FAAH (0.46) TRPV1FAAHTERTMAPTBLM
SCHEMBL25178125 0.92 FAAH (0.46) TRPV1FAAHTERTMAPTBLM
SCHEMBL21694546 0.92 FAAH (0.46) TRPV1FAAHTERTMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042328-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2023-02-09 US disclosed
CN-109715605-B Process for preparing carotenoid monoesters 巴斯夫欧洲公司 2022-04-12 CN disclosed
WO-2021122673-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2021-06-24 WO disclosed
EP-3134380-B1 METHOD FOR PRODUCING CARBOXYLIC ACID ESTERS IN THE PRESENCE OF AN IONIC LIQUID AND AN ACIDIC ESTERIFICATION CATALYST AND THE USE THEREOF AS PLASTICIZER BASF SE (DE) 2019-08-14 EP disclosed
US-9776949-B2 Process for the production of carboxylic esters and use of these as plasticizers BASF SE (DE) 2017-10-03 US disclosed
US-20170174676-A1 CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2017-06-22 US disclosed
US-20170044085-A1 PROCESS FOR THE PRODUCTION OF CARBOXYLIC ESTERS AND USE OF THESE AS PLASTICIZERS BASF SE (DE) 2017-02-16 US disclosed
EP-2074255-B1 IONIC LIQUIDS FOR SOLUBILIZING POLYMERS BASF SE (DE) 2016-12-14 EP disclosed
US-9512354-B2 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics BASF SE (DE) 2016-12-06 US disclosed
EP-2532663-B1 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors BASF SE (DE) 2016-03-16 EP disclosed
EP-0719258-A1 CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-07-03 EP disclosed
WO-1996002508-A1 CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-02-01 WO disclosed
CN-1114834-A antidiabetic agent OTSUKA PHARMA CO LTD (JP) 1996-01-10 CN disclosed
US-5306719-A Cardiotonic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-26 US disclosed
EP-0255134-B1 CARBOSTYRIL DERIVATIVES AND SALTS THEREOF, PROCESS FOR PREPARING THEM, AND CARDIOTONIC COMPOSITION CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-03 EP disclosed
US-5071856-A CARBOSTYRIL DERIVATIVES AND SALTS THEREOF OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-12-10 US disclosed
US-4886809-A CARDIOTONIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-12-12 US disclosed
US-4845100-A WITH HYPOTENSIVE AND ANTIINFLAMMATORY ACTIVITY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-04 US disclosed
EP-0255134-A2 Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-02-03 EP disclosed
EP-0202760-A2 Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174676-A1 CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS SLCO2A1, SLCO2B1, SLC43A3 TRPV1 961/4885FAAH 1134/4885TERT 3669/4885
US-20170044085-A1 PROCESS FOR THE PRODUCTION OF CARBOXYLIC ESTERS AND USE OF THESE AS PLASTICIZERS FASN, ELOVL3, ELOVL5 TRPV1 2237/4885FAAH 101/4885TERT 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.